Antimicrobial activities of human β-defensins against Bacillus species

International Journal of Antimicrobial Agents

Volumn 28, Issue 2, 2006, Pages 132-137

  Yadava, Preeti ^a   Zhang, Chun ^a   Sun, Jing ^a   Hughes, Jeffrey A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antimicrobial peptides; Bacillus; Defensin; Radial diffusion assay

Indexed keywords

BETA DEFENSIN; PEPTIDE DERIVATIVE;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS LICHENIFORMIS; BACILLUS SUBTILIS; BACILLUS THURINGIENSIS; BIOLOGICAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; BACILLUS; BETA-DEFENSINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 33746299143     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.021     Document Type: Article

References (31)

1. Ivanova N., Sorokin A., Anderson I., et al. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature 423 (2003) 87-91
2. Helgason E., Okstad O.A., Caugant D.A., et al. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Appl Environ Microbiol 66 (2000) 2627-2630
3. Yamaguchi Y., Nagase T., Makita R., et al. Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol 169 (2002) 2516-2523
4. Yang D., Chertov O., Bykovskaia S.N., et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
5. Niyonsaba F., Someya A., Hirata M., Ogawa H., and Nagaoka I. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 31 (2001) 1066-1075
6. Niyonsaba F., Iwabuchi K., Matsuda H., Ogawa H., and Nagaoka I. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 14 (2002) 421-426
7. Niyonsaba F., Ogawa H., and Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111 (2004) 273-281
8. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 (2001) 5707-5713
9. Carothers D.G., Graham S.M., Jia H.P., Ackermann M.R., Tack B.F., and McCray Jr. P.B. Production of beta-defensin antimicrobial peptides by maxillary sinus mucosa. Am J Rhinol 15 (2001) 175-179
10. Jia H.P., Schutte B.C., Schudy A., et al. Discovery of new human beta-defensins using a genomics-based approach. Gene 263 (2001) 211-218
11. Harder J., Bartels J., Christophers E., and Schroder J.M. A peptide antibiotic from human skin. Nature 387 (1997) 861
12. Bals R., Wang X., Wu Z., et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102 (1998) 874-880
13. Schroder J.M. Epithelial peptide antibiotics. Biochem Pharmacol 57 (1999) 121-134
14. Garcia J.R., Krause A., Schulz S., et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15 (2001) 1819-1821
15. Haynes R.J., McElveen J.E., Dua H.S., Tighe P.J., and Liversidge J. Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci 41 (2000) 3026-3031
16. Takemura H., Kaku M., Kohno S., et al. Evaluation of susceptibility of Gram-positive and -negative bacteria to human defensins by using radial diffusion assay. Antimicrob Agents Chemother 40 (1996) 2280-2284
17. Lehrer R.I., Rosenman M., Harwig S.S., Jackson R., and Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 137 (1991) 167-173
18. Jernigan D.B., Raghunathan P.L., Bell B.P., et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 8 (2002) 1019-1028
19. Morens D.M., Folkers G.K., and Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 430 (2004) 242-249
20. Gudmundsson G.H., and Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods 232 (1999) 45-54
21. Kim C., Gajendran N., Mittrucker H.W., et al. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci USA 102 (2005) 4830-4835
22. Leduc M., Rousseau M., and van Heijenoort J. Structure of the cell wall of Bacillus species C.I.P. 76-111. Eur J Biochem 80 (1977) 153-163
23. Potter M., Oppermann-Sanio F.B., and Steinbuchel A. Cultivation of bacteria producing polyamino acids with liquid manure as carbon and nitrogen source. Appl Environ Microbiol 67 (2001) 617-622
24. de Vries Y.P., Atmadja R.D., Hornstra L.M., de Vos W.M., and Abee T. Influence of glutamate on growth, sporulation, and spore properties of Bacillus cereus ATCC 14579 in defined medium. Appl Environ Microbiol 71 (2005) 3248-3254
25. Lopez-y-Lopez V.E., and de la Torre M. Redirection of metabolism during nutrient feeding in fed-batch cultures of Bacillus thuringiensis. Appl Microbiol Biotechnol 67 (2005) 254-260
26. Koch-Weser J., and Sellers E.M. Drug therapy. Binding of drugs to serum albumin (second of two parts). N Engl J Med 294 (1976) 526-531
27. Sudlow G., Birkett D.J., and Wade D.N. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12 (1976) 1052-1061
28. Sudlow G., Birkett D.J., and Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11 (1975) 824-832
29. Sjobring U., Falkenberg C., Nielsen E., Akerstrom B., and Bjorck L. Isolation and characterization of a 14-kDa albumin-binding fragment of streptococcal protein G. J Immunol 140 (1988) 1595-1599
30. Dennis M.S., Zhang M., Meng Y.G., et al. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem 277 (2002) 35035-35043
31. Daher K.A., Selsted M.E., and Lehrer R.I. Direct inactivation of viruses by human granulocyte defensins. J Virol 60 (1986) 1068-1074